KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) Net Income towards Common Stockholders (2019 - 2024)

Clover Health Investments' Net Income towards Common Stockholders history spans 6 years, with the latest figure at -$611000.0 for Q4 2024.

  • For Q4 2024, Net Income towards Common Stockholders rose 75.7% year-over-year to -$611000.0; the TTM value through Sep 2025 reached -$611000.0, down 145.13%, while the annual FY2024 figure was $3.3 million, 201.78% up from the prior year.
  • Net Income towards Common Stockholders reached -$611000.0 in Q4 2024 per CLOV's latest filing, down from -$370000.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $14.8 million in Q2 2020 to a low of -$187.2 million in Q4 2021.
  • Average Net Income towards Common Stockholders over 5 years is -$48.9 million, with a median of -$25.3 million recorded in 2020.
  • Peak YoY movement for Net Income towards Common Stockholders: tumbled 442637.22% in 2020, then skyrocketed 217.33% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$78.1 million in 2020, then crashed by 139.81% to -$187.2 million in 2021, then soared by 87.98% to -$22.5 million in 2022, then skyrocketed by 88.82% to -$2.5 million in 2023, then surged by 75.7% to -$611000.0 in 2024.
  • Per Business Quant, the three most recent readings for CLOV's Net Income towards Common Stockholders are -$611000.0 (Q4 2024), -$370000.0 (Q3 2024), and $238000.0 (Q2 2024).